
Daniel P. Cahn
Examiner (ID: 8692, Phone: (571)270-5616 , Office: P/3634 )
| Most Active Art Unit | 3634 |
| Art Unit(s) | 3634 |
| Total Applications | 803 |
| Issued Applications | 414 |
| Pending Applications | 11 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20452985
[patent_doc_number] => 12516035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Tocopherol derivatives and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/857879
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857879
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857879 | Tocopherol derivatives and methods of use | Jul 4, 2022 | Issued |
Array
(
[id] => 19430922
[patent_doc_number] => 20240299420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/573519
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573519
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573519 | TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS | Jun 26, 2022 | Pending |
Array
(
[id] => 17929676
[patent_doc_number] => 20220324801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHOD FOR PREPARING LEVETIRACETAM AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/847898
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847898 | Method for preparing levetiracetam and intermediates thereof | Jun 22, 2022 | Issued |
Array
(
[id] => 20788549
[patent_doc_number] => 12662453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Heterocyclic compound and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/846830
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73939
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/846830 | HETEROCYCLIC COMPOUND AND USE THEREOF | Jun 21, 2022 | Issued |
Array
(
[id] => 19403499
[patent_doc_number] => 20240287010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => Process For Making Epoxide Derivatives of Farnesene and Use Thereof in Further Synthesis
[patent_app_type] => utility
[patent_app_number] => 18/566075
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566075 | Process For Making Epoxide Derivatives of Farnesene and Use Thereof in Further Synthesis | Jun 20, 2022 | Pending |
Array
(
[id] => 19512006
[patent_doc_number] => 20240343692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => SELECTIVE PSYCHEDELIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/682031
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682031 | SELECTIVE PSYCHEDELIC COMPOUNDS | Jun 20, 2022 | Pending |
Array
(
[id] => 18117483
[patent_doc_number] => 11548864
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-10
[patent_title] => Separation of chemical species using multiple liquid phases and related systems
[patent_app_type] => utility
[patent_app_number] => 17/840914
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 19263
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840914 | Separation of chemical species using multiple liquid phases and related systems | Jun 14, 2022 | Issued |
Array
(
[id] => 18287016
[patent_doc_number] => 20230102488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOUNDS AND THEIR USE FOR THE TREATMENT OF ALPHA1-ANTITRYPSIN DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/839225
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839225 | COMPOUNDS AND THEIR USE FOR THE TREATMENT OF ALPHA1-ANTITRYPSIN DEFICIENCY | Jun 12, 2022 | Pending |
Array
(
[id] => 19151128
[patent_doc_number] => 11976024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Process for preparing cyanoacetates
[patent_app_type] => utility
[patent_app_number] => 17/838897
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3299
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838897 | Process for preparing cyanoacetates | Jun 12, 2022 | Issued |
Array
(
[id] => 18871095
[patent_doc_number] => 11858880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Anti-fungals compounds targeting the synthesis of fungal sphingolipids
[patent_app_type] => utility
[patent_app_number] => 17/837548
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25940
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837548 | Anti-fungals compounds targeting the synthesis of fungal sphingolipids | Jun 9, 2022 | Issued |
Array
(
[id] => 17913130
[patent_doc_number] => 20220315525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/837876
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 637
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837876 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | Jun 9, 2022 | Abandoned |
Array
(
[id] => 18404506
[patent_doc_number] => 20230165857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => AXL KINASE INHIBITORS AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/836698
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836698 | AXL KINASE INHIBITORS AND USE OF THE SAME | Jun 8, 2022 | Abandoned |
Array
(
[id] => 19387827
[patent_doc_number] => 20240277697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHODS OF TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH OPIATE WITHDRAWAL OR OPIATE RELAPSE
[patent_app_type] => utility
[patent_app_number] => 18/566736
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566736 | METHODS OF TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH OPIATE WITHDRAWAL OR OPIATE RELAPSE | Jun 8, 2022 | Pending |
Array
(
[id] => 18147619
[patent_doc_number] => 20230021476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
[patent_app_type] => utility
[patent_app_number] => 17/835559
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835559 | Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha | Jun 7, 2022 | Issued |
Array
(
[id] => 17882702
[patent_doc_number] => 20220298179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PROTECTIVE GROUPS AND METHODS FOR PROTECTING BENZOXABOROLES OR OXABOROLES
[patent_app_type] => utility
[patent_app_number] => 17/833345
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833345 | Protective groups and methods for protecting benzoxaboroles or oxaboroles | Jun 5, 2022 | Issued |
Array
(
[id] => 19359175
[patent_doc_number] => 20240261209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ORGANOPOLYSILOXANE-MODIFIED CYCLODEXTRIN COMPOUND AND COSMETICS CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 18/567076
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567076 | ORGANOPOLYSILOXANE-MODIFIED CYCLODEXTRIN COMPOUND AND COSMETICS CONTAINING SAME | Jun 2, 2022 | Pending |
Array
(
[id] => 17981113
[patent_doc_number] => 20220347149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION
[patent_app_type] => utility
[patent_app_number] => 17/750806
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750806 | A2-73 as a therapeutic for insomnia, anxiety, and agitation | May 22, 2022 | Issued |
Array
(
[id] => 17837655
[patent_doc_number] => 20220274960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => QUENCHER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/747863
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747863 | Quencher and uses thereof | May 17, 2022 | Issued |
Array
(
[id] => 17851777
[patent_doc_number] => 20220281819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/743408
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743408 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | May 11, 2022 | Pending |
Array
(
[id] => 18526318
[patent_doc_number] => 11713302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Sulfonamide benzamide derivative and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/663153
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4675
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/663153 | Sulfonamide benzamide derivative and preparation method and application thereof | May 11, 2022 | Issued |